Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-2-13
|
pubmed:abstractText |
The potencies and intrinsic activities on cyclic AMP accumulation and lipolysis of various selective beta 3-adrenoceptor agonists were studied in brown adipocytes and compared to those of the nonselective, (-)-isoprenaline, and conventional beta 1- (dobutamine) and beta 2-adrenoceptor (salbutamol) agonists. (-)-Isoprenaline, dobutamine and salbutamol were more potent stimulants of lipolysis than of cyclic AMP accumulation, while the selective beta 3-adrenoceptor agonists had similar potencies for these two functions. Apparent pA2 values of the selective beta 1-(CGP20712A) and beta 2-adrenoceptor (ICI118551) antagonist for inhibition of adenylyl cyclase stimulation by (-)-isoprenaline and the beta 3-adrenoceptor agonists, BRL37344, SR58611A, and ICI215001, indicated that (-)-isoprenaline can stimulate the enzyme through a relevant beta 1-adrenergic component, while the other drugs activate the enzyme mainly by acting on the beta 3-adrenoceptors. On the contrary, antagonism of the lipolysis yielded apparent pA2 values for CGP20712A and ICI118551, suggesting that (-)-isoprenaline, like all the beta 3-adrenoceptor agonists, stimulated the brown adipose tissue lipid metabolism mainly through an action on beta 3-adrenoceptors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Glycerol,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-4533
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
329
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
436-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8546541-Adipocytes,
pubmed-meshheading:8546541-Adipose Tissue, Brown,
pubmed-meshheading:8546541-Adrenergic beta-Agonists,
pubmed-meshheading:8546541-Adrenergic beta-Antagonists,
pubmed-meshheading:8546541-Animals,
pubmed-meshheading:8546541-Cyclic AMP,
pubmed-meshheading:8546541-Glycerol,
pubmed-meshheading:8546541-Lipid Metabolism,
pubmed-meshheading:8546541-Lipolysis,
pubmed-meshheading:8546541-Male,
pubmed-meshheading:8546541-Rats,
pubmed-meshheading:8546541-Rats, Sprague-Dawley,
pubmed-meshheading:8546541-Receptors, Adrenergic, beta,
pubmed-meshheading:8546541-Signal Transduction
|
pubmed:articleTitle |
Differential relevance of beta-adrenoceptor subtypes in modulating the rat brown adipocytes function.
|
pubmed:affiliation |
Department of Pharmacology, Chemotherapy and Medical Toxicology, School of Medicine, University of Milan, Italy.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|